RA
Rosalind Advisors Portfolio holdings
AUM
$244M
1-Year Est. Return
80.12%
This Fund
S&P 500
1 Year Est. Return
+80.12%
AUM
$244M
AUM Growth
-$30.4M
(-11%)
Holding
48
Top Buys
| 1 | +$15.7M | |
| 2 | +$9.87M | |
| 3 | +$9M | |
| 4 |
Xeris Biopharma Holdings
XERS
|
+$7.43M |
| 5 |
BioCryst Pharmaceuticals
BCRX
|
+$7.17M |
Top Sells
| 1 | +$13.6M | |
| 2 | +$12.4M | |
| 3 | +$11.3M | |
| 4 |
Replimune Group
REPL
|
+$10.8M |
| 5 |
DFTX
Definium Therapeutics
DFTX
|
+$10.6M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Delcath Systems
DCTH
$372M
| $30.6M | 12.55% |
3,300,389
|
|
||
|
2
Xeris Biopharma Holdings
XERS
$1.06B
| $18.7M | 7.68% |
3,231,700
+1,120,000
|
|
||
3
Fennec Pharmaceuticals
FENC
$345M
| $17.9M | 7.33% |
2,908,201
+294,693
|
|
||
4
Savara
SVRA
$1.07B
| $17.5M | 7.17% |
3,203,721
-200,000
|
|
||
5
Vaxcyte
PCVX
$7.42B
| $16.9M | 6.9% |
+290,000
|
|
||
6
EyePoint Inc
EYPT
$1.14B
| $13.4M | 5.48% |
1,036,737
+346,737
|
|
||
7
X4 Pharmaceuticals
XFOR
$407M
| $13.3M | 5.44% |
3,214,766
+608,846
|
|
||
8
Vor Biopharma
VOR
$811M
| $12.5M | 5.12% |
+700,000
|
|
||
9
MediWound
MDWD
$184M
| $12.1M | 4.94% |
749,054
|
|
||
10
Verastem
VSTM
$380M
| $11.3M | 4.64% |
2,138,475
+350,000
|
|
||
11
Celldex Therapeutics
CLDX
$2.47B
| $10.5M | 4.29% |
+330,000
|
|
||
|
12
BioCryst Pharmaceuticals
BCRX
$2.26B
| $8.79M | 3.6% |
+923,057
|
|
||
|
HELP
13
Cybin Inc
HELP
$227M
| $7.35M | 3.01% |
1,531,814
-125,726
|
|
||
14
CG Oncology
CGON
$5.49B
| $6.77M | 2.77% |
100,000
-200,000
|
|
||
15
InspireMD
NSPR
$43.1M
| $6.37M | 2.61% |
3,905,743
|
|
||
16
Atea Pharmaceuticals
AVIR
$374M
| $6.3M | 2.58% |
+1,171,855
|
|
||
|
PROF
17
Profound Medical
PROF
$247M
| $5.37M | 2.2% |
828,118
-240,837
|
|
||
18
Viridian Therapeutics
VRDN
$1.95B
| $4.9M | 2.01% |
250,401
-199,599
|
|
||
19
PolyPid
PYPD
$90.5M
| $2.62M | 1.07% |
597,926
-98,630
|
|
||
20
Myomo
MYO
$42.1M
| $2.6M | 1.06% |
3,847,272
+7,500
|
|
||
21
Talphera
TLPH
$42.4M
| $2.51M | 1.03% |
3,353,916
-225,357
|
|
||
22
Ovid Therapeutics
OVID
$510M
| $2.46M | 1.01% |
+1,107,994
|
|
||
|
DFTX
23
Definium Therapeutics
DFTX
$2.64B
| $2.36M | 0.97% |
125,000
-625,000
|
|
||
|
OKUR
24
OnKure Therapeutics
OKUR
$170M
| $1.84M | 0.75% |
443,763
-286,725
|
|
||
25
Lipocine
LPCN
$18.5M
| $1.77M | 0.73% |
+221,616
|
|